Mutations of the VHL tumour suppressor gene in renal carcinoma

Nature Genetics

Volumn 7, Issue 1, 1994, Pages 85-90

  Gnarra, J R ^a   Tory, K ^b   Weng, Y ^a   Schmidt, L ^b   Wei, M H ^b   Li, H ^b   Latif, F ^b   Liu, S ^a   Chen, F ^b   Duh, F M ^b   Lubensky, I ^a   Duan, D R ^a   Florence, C ^a   Pozzatti, R ^a   Walther, M M ^a   Bander, N H ^c   Grossman, H B ^d   Brauch, H ^e   Pomer, S ^f   Brooks, J D ^g   Isaacs, W B ^g   Lerman, M I ^b   Zbar, B ^b   Linehan, W M ^a   more..

^a NATIONAL CANCER INSTITUTE   (United States)

^b NATIONAL CANCER INSTITUTE   (United States)

^c WEILL CORNELL MEDICAL CENTER   (United States)

^d UNIVERSITY OF MICHIGAN   (United States)

^e TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^f UNIVERSITY HOSPITAL HEIDELBERG   (Germany)

^g DEPARTMENT OF PATHOLOGY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CARCINOGENESIS; CLEAR CELL CARCINOMA; FAMILIAL CANCER; GENE MUTATION; GENE TRANSLOCATION; GENETIC HETEROGENEITY; HUMAN; KIDNEY CARCINOMA; PRIORITY JOURNAL; SOMATIC MUTATION; TUMOR LOCALIZATION; TUMOR SUPPRESSOR GENE; VON HIPPEL LINDAU DISEASE;

ADENOCARCINOMA, CLEAR CELL; BASE SEQUENCE; CARCINOMA; DNA MUTATIONAL ANALYSIS; DNA, NEOPLASM; GENES, TUMOR SUPPRESSOR; HIPPEL-LINDAU DISEASE; HUMAN; KIDNEY NEOPLASMS; MOLECULAR SEQUENCE DATA; MUTATION; NEOPLASMS, SECOND PRIMARY; ORGAN SPECIFICITY; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH; SEQUENCE DELETION; SUPPORT, NON-U.S. GOV'T;

EID: 0027954044     PISSN: 10614036     EISSN: 15461718     Source Type: Journal    
DOI: 10.1038/ng0594-85     Document Type: Article

References (28)

1. Knudson, A.G. Hereditary cancer, oncogenes, and antloncogenes. Cancer Res. 45, 1437-1443 (1985).
2. Maher, E.R. et al. von Hippel-Lindau disease: a genetic study. J. med. Genet. 28, 443-447 (1991).
3. Linehan, W.M., Gnarra, J.R., Lerman, M.I., Latif, F. & Zbar, B. Genetic basis of renal cell cancer in Important Advances in Oncology (eds DeVita, V. T. et al) 47-70 (J.B. Lippincott Company, Philadelphia, 1993).
4. Lamiell, J.M., Salazar, F.G. & Hsia, Y.E. von Hippel-Lindau disease affecting 43 members of a single kindred. Medicine 68, 1-29 (1989).
5. Glenn, G.M., Choyke, P.L., Zbar, B. & Linehan, W.M. von Hippel-Lindau disease: clinical review and molecular genetics. Problems Urol. 4, 312-330 (1990).
6. Latif, F. et al. Identification of the von Hippel-Lindau disease tumour suppressor gene. Science 260, 1317-1320 (1993).
7. Cohen, A.J. et al. Hereditary renal cell carcinoma associated with a chromosomal translocation. New Engl. J. Med. 301, 592-595 (1979).
8. Li, F.P. et al. Clinical and genetic studies of renal cell carcinomas in a family with a constitutional chromosome 3;8 translocation. Ann. int. Med.118, 106-111 (1993).
9. Farrow, G.M. Diseases of the kidney in Urological Pathology (ed Murphy, W. M.) 409-482 (W.B. Saunders Company, Philadelphia, 1989).
10. Kovacs, G. Papillary renal cell carcinoma: a morphologic and cytogenetic study of 11 cases. Am. J. Path. 134, 27-34 (1989).
11. Kovacs, G., Fuzesi, L., Emanuel, A. & Kung, H.-F. Cytogenetics of papillary renal cell tumors. Genes Chrom. Cancer 3, 249-255 (1991).
12. Zbar, B. et al. Hereditary papillary renal cell carcinoma. J. Urol. 151, 561-566 (1994).
13. Anglard, P. et al. Molecular analysis of genetic changes in the origin and development of renal cell carcinoma. Cancer Res. 51, 1071-1077 (1991).
14. Anglard, P. et al. Molecular and cellular characterization of human renal cell carcinoma cell lines. Cancer Res. 52, 348-356 (1992).
15. Brooks, J.D., Bova, G.S., Marshall, F.F. & Isaacs, W.B. Tumour suppressor gene allelic loss in human renal cancers. J. Urol. 150, 1278-1283 (1993).
16. Makos, M. et al. Regional DNA hypermethylation at D17S5 precedes 17p structural changes in the progression of renal tumors. Cancer Res. 53, 2719-2722 (1993).
17. Reiter, R.E., Anglard, P., Liu, S., Gnarra, J.R. & Linehan, W.M. Chromosome 17p deletions and p53 mutations in renal cell carcinoma.Cancer Res. 53, 3092-3097 (1993).
18. Mulligan, C.M. et al. Specific mutations of the RET proto-oncogene are related to disease phenotype in MEN 2A and FMTC. Nature Genet. 6, 70-74 (1994).
19. Donis-Keller, H. et al. Mutations in the RET proto-oncogene are associated with MEN 2A and FMTC. Hum. molec. Genetic. 2, 851-856 (1993).
20. Hofstra, R.M.W. et al. A mutation in the RET proto-oncogene associated with multiple endocrine neoplasia type 2B and sporadic medulary thyroid carcinoma. Nature 367, 375-376 (1994).
21. Romeo, G. et al. Point mutations affecting the tyroslne kinase domain of the RET proto-oncogene in Hirschsprung's disease. Nature 367, 377-378 (1994).
22. Edery, P. et al. Mutations of the RET proto-oncogene in Hirschsprung's disease. Nature 367, 378-380 (1994).
23. Grossman, H.B., Wedemeyer, G. & Ren, L. Human renal carcinoma: characterization of five new cell lines. J. surg. Oncol. 28, 237-244 (1985).
24. Ebert, T., Bander, N.H., Finstad, C.L., Ramsawak, R.D. & Old, L.J. Establishment and characterization of human renal cancer and normal kidney cell lines. Cancer Res. 50, 5531-5536 (1990).
25. Shrivastav, S., Sharief, Y., Day, J., Reich, C.F. & Bonar, R. Establishment and characterization of a cell line (SS78) from a human renal cell carcinoma. In Vitro 12, 1117-1124 (1981).
26. Robson, C.J., Churchill, B.M. & Anderson, W. The results of radical nephrectomy for renal cell carcinoma. J. Urol. 101, 297-301 (1969).
27. Zeiger, M.A., Gnarra, J.R., Zbar, B., Linehan, W.M. & Pass, H.I. Loss of heterozygosity on the short arm of chromosome 3 in mesothelioma cell lines and solid tumors. Genes Chrom. Can. (in the press).
28. Herrmann, M.A. et al. Cytogenetic and moleculargenetic studies of follicular and papillary thyroid cancers. J. clin. Invest. 88, 1596-1604 (1991).